INS and metabolic syndrome: Components of the metabolic syndrome were selected by these organizations, because they tend to cluster commonly in insulin resistant individuals who are at increased risk of CVD, beyond the risk implicated by classical CVD risk factors, like elevated low density lipoprotein cholesterol (LDL-C) levels [5,8,13-15].